Algiplex

About Algiplex

Algiplex is a UK-based biotechnology company focused on commercial algae cultivation. It develops microbial ecosystem technology designed to make algae farms more productive and more resilient by improving the biological environment around the crop rather than modifying the algae itself.

The company positions its platform as a practical bridge between laboratory synthetic ecology and real-world farming. It is currently seeking early commercial deployments in selected locations and is working with algae producers and strategic partners to scale the technology across more farms, species, and markets.

Core Values

• Productivity: The company’s core goal is to help algae farms produce more by improving yields and overall cultivation performance.
• Resilience: Algiplex emphasizes protecting crops against contamination and other biological instability that can cause crop loss.
• Translation from science to practice: The team highlights its focus on turning laboratory biology into a commercially deployable system that works under real cultivation conditions.
• Collaboration: Algiplex presents partnership as central to scaling the technology across species, systems, and markets.

Unique Aspects

• Ecosystem-first approach: Rather than engineering the algae itself, Algiplex engineers the microbial ecosystem around it, which is a distinctive way to improve cultivation outcomes.
• Reported trial performance: In laboratory trials, the company says its best-performing ecosystems delivered up to 8.5× productivity while preventing contamination-driven crop loss.
• Founding expertise: Algiplex was founded by Oxford researchers Georgina Whichello and Dr Cherilyn Lee, combining chemistry, molecular biology, and microbial ecosystem expertise.
• Early commercial deployment stage: The company is already accepting interest for first deployments in selected locations, indicating a move beyond concept toward real-world use.